AHCO News and Press, AdaptHealth Corp. From 08/10/21

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its subsidiary...

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today the appointment of ...

AdaptHealth Corp. (AHCO) Q2 2021 Earnings Conference Call August 5, 2021, 8:30 AM ET Company Participants Christopher Joyce - General Counsel Steve Griggs - Chief Executive Officer Joshua Parnes - President Jason Clemens - Chief Financial Officer Conference Call Participants Brian Tanquilut -...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In AdaptHealth To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - August 6, 2021) -  Faruqi & Faruqi, LLP, a leading national securities la...

Image source: The Motley Fool. AdaptHealth Corp. (NASDAQ: AHCO) Q2 2021 Earnings Call Aug 05, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: AdaptHealth Corp. (AHCO) Q2 2021 Earnings Call Transcript

The following slide deck was published by AdaptHealth Corp. in conjunction with their 2021 Q2 earnings call. For further details see: AdaptHealth Corp. 2021 Q2 - Results - Earnings Call Presentation

Gainers: Profound Medical (NASDAQ:PROF) +28%, STAAR Surgical (NASDAQ:STAA) +19%, AdaptHealth (NASDAQ:AHCO) +17%, Flora Growth (NASDAQ:FLGC) +16%, Invacare (NYSE:IVC) +15%. Losers: Inogen (NASDAQ:INGN) -32%, Karyopharm Therapeutics (NASDAQ:KPTI) ...

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results f...

AdaptHealth (AHCO) dropped 3.5% in premarket trading after a new short report from Jehoshaphat Research.The short call alleges the "roll-up"  company appears to be using questionable financial reporting practices.AdaptHealth short interest is 4.35% of float.AdaptHealth didn't i...

Mario13/E+ via Getty Images Roche upgraded Jefferies on Alzheimer’s prospects Expecting Roche (RHHBY) to confirm its intention to pursue an expedited U.S. filing for marketing approval of Alzheimer’s therapy gantenerumab, Jefferies has upgraded the stock to buy from hold. The pr...